Release Date: 30/04/20 13:45 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 216.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%